key: cord-0910121-xyxyg3mf
authors: Niranji, Sherko S.; Al-Jaf, Sirwan M.M.
title: Comments on ‘Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2’
date: 2020-12-02
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2020.104661
sha: ae24aec55ad03eeefdc99258fc0f08fe142a341f
doc_id: 910121
cord_uid: xyxyg3mf

nan

: Short nucleotide sequences of severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome (NCBI Reference Sequence: NC_045512.2). A1841 is the target for D614G mutation. But T1845 is a target for V615. The (gat) is a codon for Aspartate (D614). The (gtt) is a codon for Valine (V615). When gtt is changed to gtg, which is a codon for Valine too, thus, T1845G mutation leads to V615V, a silent mutation, not D614G.

We think that Hashemi et al have made a mistake that instead of identifying D614G but they have developed a novel method for exploring V615V which is a silent mutation that occurred in Iranian populations when GTT (Valine) is changed to GTG (Valine).

The site of this mutation appears to be rarely targeted in the world as in recent studies, the nucleotide G23405 in the whole genome or G1843 in the spike genome in GTT codon (Valine), is mutated to C23405 or C1843 forming CTT codon (Leucine) and thus the mutation is called V615L (G23405C in the whole genome or G1843C in the spike genome), which has been seldomly reported in the world (Koyama et al., 2020; Li et al., 2020; Yang et al., 2020) .

Because GTG (Valine), which was mistakenly mentioned as Glycine by Hashemi et al, has been confirmed using DNA sequencing, therefore, we may not envisage the V615L (G23405C or G1843C) variant in the Iranian samples. An in vitro study shows that the V615L play roles in structural impacts and antibody sensitivity of SARS CoV-2 spike protein (Li et al., 2020) . However, the roles of silent mutations such as V615V, reported by Hashemi et al, should be elucidated in evolutionary perspectives.

In fact, Hashemi et al have found a novel silent mutation, V615V (T23407G in the whole genome or T1845G in the spike genome) which has been prevalent in 9 % of positive samples taken from an intensive care unit of North-eastern Iran within the last six months that may have important roles in increasing infectivity of the virus or it could have occurred due to a random mutation. Therefore, we recommend correcting this paper as a corrigendum to be entitled (Development of a PCR-RFLP method for the detection of V615V mutation in SARS-CoV-2). 

COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest

Development of a PCR-RFLP method for detection of D614G mutation in SARS-CoV-2

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Emergence of Drift Variants That

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Spike mutation D614G alters SARS-CoV-2 fitness

Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries

Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020